Lantern Pharma Inc. hosted an Investor and Analyst Day in New York City on January 22, 2026, highlighting its AI Center of Excellence strategic initiative and announcing the initial rollout of its major platform. The event featured live demonstrations of Lantern's new AI-driven tools and multi-agentic system designed to address underserved needs in cancer treatment. Attendees received insights into Lantern’s AI industrialization strategy, the expanded capabilities of the RADR® platform, and the company's phased deployment roadmap, with a focus on future biopharma partnerships and revenue opportunities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantern Pharma Inc. published the original content used to generate this news brief on January 12, 2026, and is solely responsible for the information contained therein.